HAEMONETICS CORP — Director's Dealing 2021

May 14, 2021

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: HAEMONETICS CORP (HAE)
CIK: 0000313143
Period of Report: 2021-04-03

Reporting Person: KROLL MARK W (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-09-11	Common Stock	G	334	—	Disposed	20067	Direct
2020-09-14	Common Stock	G	167	—	Disposed	19900	Direct

Footnotes

F1: Shares transferred as a bona fide gift without any consideration.

F2: This number includes unvested restricted stock units previously reported.